XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Segment Reporting | 3 Months Ended
--- | ---
Mar. 31, 2017
Segment Reporting [Abstract] |
Segment Reporting | Note 1 4. Segment Reporting Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include diagnostic and information technology-based products and services for the veterinary market, which we refer to as the Companion Animal Group (“CAG”), water quality produc ts (“Water”) and diagnostic product s and services for livestock and poultry health and to ensure the quality and safety of milk and food, which we refer to as Livestock, Poultry and Dairy (“LPD”). Our Other operating segment combines and presents products for the human point-of-care medical diagnostics market with our pharmaceutical product line and our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments. ﻿ Certain costs are not allocated to our operating segments and are instead reported under the caption “Unallocated Amounts”. These costs include costs that do not align with one of our existing operating segments or are cost prohibitive to allocate, which primarily consist of our R&D function, regional or country expenses, certain foreign currency revaluation gains and losses on monetary balances in currencies other than our subsidiaries’ functional currency and unusual items. Corporate support function costs (such as information technology, facilities, human resources, finance and legal), health benefits and incentive compensation are charged to our business segments at pre-determined budgeted amounts or rates. Differences from these pre-determined budgeted amounts or rates are captured within Unallocated Amounts. The following is a summary of segment p erformance for the three months ended March 3 1, 201 7 and 201 6 (in thousands): ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | For the Three Months Ended March 31, |
﻿ |  |  | CAG |  | Water |  | LPD |  | Other |  | Unallocated Amounts |  | Consolidated Total |
﻿2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Revenue |  | $ | 403,227 |  | $ | 25,077 |  | $ | 29,317 |  | $ | 4,400 |  | $ | - |  | $ | 462,021 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Income (loss) from operations |  | $ | 79,855 |  | $ | 10,263 |  | $ | 3,802 |  | $ | 393 |  | $ | (2,070) |  | $ | 92,243 |
﻿Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (7,506) |
﻿Income before provision for income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 84,737 |
﻿Provision for income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15,679 |
﻿Net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 69,058 |
﻿Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 39 |
﻿Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 69,019 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Revenue |  | $ | 357,639 |  | $ | 23,552 |  | $ | 30,856 |  | $ | 5,503 |  | $ | - |  | $ | 417,550 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Income (loss) from operations |  | $ | 61,378 |  | $ | 9,679 |  | $ | 4,570 |  | $ | (837) |  | $ | (997) |  | $ | 73,793 |
﻿Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (7,484) |
﻿Income before provision for income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 66,309 |
﻿Provision for income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,284 |
﻿Net income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 46,025 |
﻿Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 |
﻿Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 46,019 |
﻿ ﻿ The following is a summary of revenue by product and servic e category for the three months ended March 3 1, 201 7 and 201 6 (in thousands):
﻿ |  |  |  |  |  |  |
﻿ |  | For the Three Months Ended |
﻿ |  | March 31, |
﻿ |  |  | 2017 |  |  | 2016 |
﻿CAG segment revenue: |  |  |  |  |  |  |
﻿CAG Diagnostics recurring revenue: |  | $ | 346,680 |  | $ | 305,841 |
﻿IDEXX VetLab consumables |  |  | 123,553 |  |  | 107,969 |
﻿Rapid assay products |  |  | 47,895 |  |  | 43,086 |
﻿Reference laboratory diagnostic and consulting services |  |  | 159,069 |  |  | 140,708 |
﻿CAG Diagnostics service and accessories |  |  | 16,163 |  |  | 14,078 |
﻿CAG Diagnostics capital - instruments |  |  | 26,183 |  |  | 22,643 |
﻿Veterinary software, services and diagnostic imaging systems |  |  | 30,364 |  |  | 29,155 |
﻿CAG segment revenue |  |  | 403,227 |  |  | 357,639 |
﻿ |  |  |  |  |  |  |
﻿Water segment revenue |  |  | 25,077 |  |  | 23,552 |
﻿LPD segment revenue |  |  | 29,317 |  |  | 30,856 |
﻿Other segment revenue |  |  | 4,400 |  |  | 5,503 |
﻿Total revenue |  | $ | 462,021 |  | $ | 417,550 |
﻿

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration